Company intelligence / Profile preview

OcuDyne

Saint Paul, Minnesota, United Statesocudyne.com ↗

Ownership: Private
Development stage: Phase 2

Overview

The OPTiC System™ pilot clinical trial demonstrated procedural feasibility of ophthalmic artery angioplasty for treating vascular lesions in geographic atrophy due to AMD. The study showed a positive safety profile with all adverse events resolving without sequelae. Subjective improvements were seen in visual function measures such as Best-Correlatred Visual Acuity and reading speed, while objective evidence included growth inhibition of geographic atrophy and increased choroidal thickness. These results support further pivotal trials and regulatory submissions.

Therapeutic areas: Ophthalmology
Modalities: DeviceMinimally invasive therapeutic deviceCardiovascular therapy (applied to ocular disease)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

OPTiC System

Phase 2

Indications: Age-related macular degeneration, Geographic atrophy

Partnerships

None publicly disclosed as of June 2025.

Beyond the preview

Go deeper on OcuDyne.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OcuDyne.

Explore the full profile